The resistance of tuberculosis bacteria is an increasingly serious problem worldwide.

Resistance arises at:

  • Irregular or intermittent intake of tablets
  • Lacking patient education
  • Insufficient monitoring of tablet intake
  • Non-simultaneous tablet intake
  • Taking only of e.g. one drug instead of all drugs according to the prescribed scheme

Tuberculosis patients who are resistant to one or more medications cannot be treated with the usual standard therapy.

In these patients it is necessary to go on medication of the so called second choice, such as Amikacin, Fluoroquinolones, Tericidone, which unfortunately have stronger side effects and are much more expensive.

The therapeutic success is significantly lower.

The frequency of multiple drug resistance (MDR) has increased worldwide in recent years. Thus, the routine testing of resistance is urgently needed.